Current
7.0×
5-Year Average
5.7×
All-Time High
8.3×
All-Time Low
2.8×
P/B Ratio daily chart for Johnson & Johnson (JNJ)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
P/B ratio is not shown for periods when book value was negative.
Historical P/B Ratio for Johnson & Johnson (JNJ) from 2001 to 2025
| 2025 | $504.08B | $81.54B | 6.2× | +1.4× | |
| 2024 | $345.01B | $71.49B | 4.8× | -0.7× | |
| 2023 | $377.30B | $68.77B | 5.5× | -0.5× | |
| 2022 | $461.69B | $76.80B | 6.0× | -0.1× | |
| 2021 | $449.74B | $74.02B | 6.1× | -0.5× | |
| 2020 | $414.30B | $63.28B | 6.5× | +0.1× | |
| 2019 | $384.00B | $59.47B | 6.5× | +0.6× | |
| 2018 | $351.53B | $59.75B | 5.9× | -0.4× | |
| 2017 | $375.13B | $60.16B | 6.2× | +1.8× | |
| 2016 | $311.82B | $70.42B | 4.4× | +0.5× | |
| 2015 | $283.01B | $71.15B | 4.0× | -0.2× | |
| 2014 | $291.04B | $69.75B | 4.2× | +0.7× | |
| 2013 | $258.34B | $74.05B | 3.5× | +0.5× | |
| 2012 | $194.77B | $64.83B | 3.0× | -0.1× | |
| 2011 | $178.94B | $57.08B | 3.1× | +0.1× | |
| 2010 | $169.65B | $56.58B | 3.0× | -0.5× | |
| 2009 | $177.64B | $50.59B | 3.5× | -0.4× | |
| 2008 | $165.99B | $42.51B | 3.9× | -0.5× | |
| 2007 | $190.47B | $43.32B | 4.4× | -0.5× | |
| 2006 | $192.28B | $39.32B | 4.9× | +0.3× | |
| 2005 | $179.39B | $38.71B | 4.6× | -1.3× | |
| 2004 | $188.24B | $31.81B | 5.9× | +0.2× | |
| 2003 | $153.33B | $26.87B | 5.7× | -1.3× | |
| 2002 | $159.73B | $22.70B | 7.0× | -0.4× | |
| 2001 | $179.37B | $24.23B | 7.4× | — |
- 20256.2×
- 20244.8×
- 20235.5×
- 20226.0×
- 20216.1×
- 20206.5×
- 20196.5×
- 20185.9×
- 20176.2×
- 20164.4×
- 20154.0×
- 20144.2×
- 20133.5×
- 20123.0×
- 20113.1×
- 20103.0×
- 20093.5×
- 20083.9×
- 20074.4×
- 20064.9×
- 20054.6×
- 20045.9×
- 20035.7×
- 20027.0×
- 20017.4×
About P/B Ratio at Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ) P/B ratio is 7.0× as of June 5, 2026. The 5-year average is 5.7×. The sector median currently stands at 3.4×. The current ratio is at the 97th percentile of its own 10-year history.
Johnson & Johnson (JNJ) historical P/B ratio has ranged from a low of 2.8× (2011) to a high of 8.3× (2002) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Johnson & Johnson P/B Ratio by Year
Johnson & Johnson P/B Ratio 2025: 6.2×
Johnson & Johnson (JNJ) P/B ratio in 2025 was 6.2×, expanded from 4.8× the prior year.
Johnson & Johnson P/B Ratio 2024: 4.8×
Johnson & Johnson (JNJ) P/B ratio in 2024 was 4.8×, contracted from 5.5× the prior year.
Johnson & Johnson P/B Ratio 2023: 5.5×
Johnson & Johnson (JNJ) P/B ratio in 2023 was 5.5×, contracted from 6.0× the prior year.
Johnson & Johnson P/B Ratio 2022: 6.0×
Johnson & Johnson (JNJ) P/B ratio in 2022 was 6.0×, contracted from 6.1× the prior year.
Johnson & Johnson P/B Ratio 2021: 6.1×
Johnson & Johnson (JNJ) P/B ratio in 2021 was 6.1×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Johnson & Johnson (JNJ), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric